ASX News Health Care Nyrada pushes through to third cohort in Phase 1 trial for NYR-BI03 Nyrada Inc has been given the go-ahead to a third cohort in its Phase 1 clinical… Caroline Smith2 mins02 May 2025 12:07 (AEST)
ASX News Health Care Monash tests show strong cardioprotective qualities for Algorae drug candidate Algorae Pharmaceutical Ltd has completed preclinical tests on its drug candidate for heart disease, AI-168 Caroline Smith2 mins29 November 2024 10:43 (AEST)